T1	Participants 131 163	superficial basal cell carcinoma
T2	Participants 305 344	superficial basal cell carcinoma (sBCC)
T3	Participants 354 371	Patients (n = 32)
T4	Participants 707 731	30 patients (13 females)
T5	Participants 1325 1329	sBCC
